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Abstract: Changes in airway inflammation by glucocorticoids were examined in 26
patients with bronchial asthma, divided into two age groups; 20-59 and 60+ years,
in relation to serum immunoglobulin levels and peripheral lymphocyte count.
1 . The levels of IgG, IgA and IgM were significantly lower in patients with
steroid-dependent intractable asthma (SOIA) of age over 60 years than in those with
non-SOIA of the same age group. In patients between the ages of 20 and 59, only
serum IgG level was significantly lower in SOIA than in non-SOIA patients.
2. Peripheral lymphocyte count was significantly decreased in SOIA patients than in
non-SOIA patients in age group over 60, but not in age group between 20 and 59.
3. Number of lymphocytes in bronchoalveolar lavage (BAL) fluid was significantly
lower and number of BAL neutrophils was significantly higher in SOIA patients than
in non-SOIA patients in age group over 60, but not in age group between 20 and 59.
These results suggest that levels of IgG, IgA and IgM, and peripheral lymphocyte
count were significantly suppressed in SOIA patients of age over 60, accompanied with
decrease of BAL lymphocytes and increase of BAL neutrophils.
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Introduction
In recent years, it has been shown that
airway inflammation is a common feature of
bronchial asthma (1 - 4 ), and that the
inflammation is clearly related to late asth-
matic reaction (LAR)( 5 , 6). In the process
of airway inflammation, lymphocytes, neutr-
ophils, eosinophils and basophils migrate into
local allergic reaction sites of airways (7 -
12). Of these cells, lymphocytes and eosin-
ophils have been noted as being main cells
participating in inflammatory process.
Our previous studies have shown that
asthma is classified into three clinical types
according to symptoms and signs: Ia. simple
bronchoconstriction type, lb. bronchoconstric-
tion + hypersecretion type, and II bronchio-
lar obstruction type (13 ~ 15). The clinical
asthma types are also related to cellular
composition of bronchoalveolar lavage (BAL)
fluid. In type Ib asthma, an increase in num-
ber of BAL eosinophils is often observed.
Type II asthma is characterized by an in-
creased number of BAL neutrophils, accompa-
nied with marked decrease in the values of
ventilatory function. An increased number of
BAL neutrophils, accompanied with a de-
crease in number of BAL lymphocytes, is
sometimes observed in asthmatic patients
with long-term glucocorticoid therapy (16-
18). However, an increase in number of BAL
neutrophils is not always found in patients
with steroid-dependent intractable asthma
(SDIA).
In the present study, to analyze the mecha-
nism of an increase in BAL neutrophil count,
serum immunoglobulin levels, peripheral
lymphocyte count, and cellular composition
of BAL fluid were examined in patients with
SDIA in relation to patient age.
Subjects and Methods
The subjects of this study were 26 patients
with bronchial asthma (12 females and 14
males, mean 53.2 years, range 21-71 years).
The mean level of serum IgE was 492 IU/mil
(range 11 - 3058 IU/mR). All the subjects
were non-smokers. Of these subjects 13 were
regarded as having steroid-dependent intracta-
ble asthma (SDIA), since they had been
treated with glucocorticoids for more than
2 years. The subjects were divided into two
groups according to age; 20 - 59 and 60+
years.
Bronchoalveolar lavage (BAL) was per-
formed after informed consent was obtained
from all the subjects. The BAL was carried
out in all study subjects by a previously
reported method (14 -18) when their attacks
were stable with predonisolone of 5 mg/day
or less. Briefly, the aspirates were centri-
fuged at 1200 rpm for 10 min at 4°C after
filtration though a sterile steel mesh, and the
resultant cell pellet was resuspended in Tris
ACM. After total cell number was counted,
smear praparations made with the cell sus-
pensions were stained with May Giemsa. A
differential cell count was performed on 500
cells, excluding epithelial cells. In the present
study, the mean recovery rate at BAL was
28.3 ± 12.4% (± SD), and the total cell
number was 6.5 ± 3.1 X 10'. The results were
expressed as /mP.
The levels of serum IgG, IgA, and IgM were
measured by turbidometric
Serum IgE level was estimated
unosorbent test (RIST).
Results
Table 1 shows characteristics of patients
with bronchial asthma divided by age and
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Table 1. Characteristics of patients with
bronchial asthma studied
asthma severity. The subjects between the
ages of 20 and 59 years consisted of 8
patients with SDIA and 8 with non-SDIA.
While the subjects over age 60 years com-
prised 5 SDIA patients and 5 non-SDIA.
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Serum IgE
(IU/ml)Sex
No of Age
Asthma subjects (years)
F 4 430
SDIA 13 43.4 M4 ± 451 Fig. 1 a. Serum immunoglobulin levels III
patients with SDIA (_ ) and
F 3 823 non-SDIA ( ) over the age of
Non-SDIA 13 46.2 M5 ± 979 60 years. a and b ; p<O.OOl, c and
d ; p<0.05, e and f ; p<O.OOl.
Regarding serum levels of immunoglobulins,
the levels of IgG, IgA and IgM were signifi-
cantly lower in SDIA patients over age 60
than in non-SDIA patients of the same age
group (IgG and IgM; p<O.OOl, IgA;
p<0.05)(Fig. 1 a). In contrast, only serum
IgG level was significantly lower in patients
with SDIA than in those with non-SDIA in
the age group between 20 and 59 (p<O.OOl).
There was no significant difference in serum
levels of IgA and IgM between them, as
shown in Fig. 1 b. Peripheral neutrophil
count was not significantly different between
SDIA and non-SDIA patients over age 60, as
shown in Fig. 2 a. While peripheral lympho-
cyte count was significantly more decreased
in patients with SDIA over age 60 than in
those with non-SDIA of the same age group.
In contrast, in age group between 20 and 59
years, numbers of peripheral neutrophils and
lymphocytes were not significantly different
between SDIA and non-SDIA patients, as
shown in Fig. 2 b.
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Fig. 1 b. Serum immunoglobulin levels in
patients with SDIA (_ ) and
non-SDIA (D) between the ages
of 20 and 59 years. a and b ; p<
0.001.
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Number of BAL eosinophils was not signifi-
cantly different between two asthma groups
over age 60. In contrast, in age group be-
tween 20 and 59, number of BAL lymphocytes
and neutrophils were not significantly differ-
ent . between SDIA and non-SDIA patients.
BAL eosinophil count was not significantly
different between them (Table 2).
Fig. 2 a. Peripheral leucocyte count III pa-
tients with SDIA ( _ ) and
non-SDIA ( ) over the age of
60 years. a and b ; p<O.Ol. Ages between 20 and 59
Table 2. Cellular composition in BAL fluid
of patients with SDIA and non-
SDIA
Neutrophils Lymphocytes
Asthma Recovery No of total No of SAL cells (xl 04 1m!)
rate(%) cells(xl0 6 ) Mac Lym Neut Eos
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Fig. 2 b. Peripheral leucocyte count in pa-
tients with SDIA ( _ ) and
non-SDIA ( ) between the ages
of 20 and 59 years.
Table 2 shows the results of cellular
composition of bronchoalveolar lavage (BAL)
fluid in study patients. Number of BAL
lymphocytes was significantly lower in pa-
tients with SDIA over age 60 than in those
with non-SDIA of the same age group
(p<O.01). In these patients with decreased
number of BAL lymphocytes, number of BAL
neutrophils was significantly larger in SDIA
patients than in non-SDIA patients (p<0.05).
SOIA 31.0 6.3 14.8 1.4 0.41 2.15
±11.9 %1.8 ±16.9 ±1.5 ±0.29 ±2.3
Non-SOIA 35.0 7.8 12.0 2.7 0.15 1.59
±14.7 ±3.6 ±6.9 ±1.2 ±0.1 ±3.2
Ages over 60
SOIA 19.3 4.5 6.8 0.8a 5.1 b 2.27
± 6.0 ±3.6 ±7.5 ±0.7 ±5.8 '14.8
NON-SOIA 22.8 6.9 14.5 3.7a 0.56b 1.57
±3.4 ±3.4 ±5.2 ±2.6 ±0.37 %2.1
SDIA;steroid-dependent intractable asthma,
Mac;macrophages. Lym;lymphocytes, Neut;neutrophils,
Eos;eosinophils. a;p<O.Ol. b;p<O.05.
Discussion
There are increasing evidences that asthma
has inflammatory process in the airways as a
main pathogenesis of the disease (1-4). The
role of inflammatory cells such as lympho-
cytes (7-9), neutrophils (16-18), eosinophils
(10,11), and basophils, which migrate from
bloodstream, have been extensively studied in
patients with bronchial asthma. It has been
reported that numbers of activated T-
lymphocytes and eosinophils in BAL fluid are
increased in asthma attacks compared to
healthy subjects (12). Long-term glucocorti-
coid therapy may affect these inflammatory
cells in patients with asthma.
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Long-term glucocorticoid regimen brings
about many side effects such as hypertention,
diabetes mellitus, osteoporosis, muscle atro-
phy, suppression of adrenocortical glands and
suppression of humoral and cellular immu-
nity. Of these side effects, immunosuppressi-
on by glucocorticoids should be noted, since
it may affect inflammatory process in the
airways of asthma, and be related to asthma
severity. In the present study, changes in
cellular composition of BAL fluid by
glucocorticoids were examined in patients
with bronchial asthma in relation to serum
immunoglobulin levels and peripheral lympho-
cyte count.
The data obtained here showed that serum
immunoglobulin levels, IgG, IgA and IgM,
and peripheral lymphocyte count were more
decreased in patients with steroid-dependent
intractable asthma (SDIA) over age of 60
years than in those with non-SDIA of the
same age group. In these SDIA patients with
a decrease in serum immunoglubulin levels
and peripheral lymphocyte count, a decrease
in number of BAL lymphocytes and an In-
crease in BAL neutrophil count were ob-
served. These results suggest that immunosu-
ppression (expressed by decreased levels of
serum immunoglobulins and decreased number
of peripheral lymphocytes) by glucocorticoids
leads to changes in numbers of BAL cells,
particularly lymphocytes and neutrophils in
asthma patients over age 60. In contrast, the
numbers of lymphocytes and neutrophils in
BAL fluid were not significantly different
between SDIA and non-SDIA patients between
20 and 59.
It is suggested from these results that
glucocorticoids should be carefully used not
to induce immunosuppression in elderly pa-
tients with bronchial asthma.
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気管支喋息26例 (ステロイド依存性重症難治性
鳴息,SDIA13例,非SDIA13例)を対象に,血
清免疫グロブリン,IgG,IgAおよびIgM値,およ
び末梢血リンパ球数との関連のもとに,副腎皮質
ホルモン長期投与による気道炎症細胞の出現頻度
の変化について検討を加えた｡なお,年齢による
影響を観察する目的で,SDIAおよび非SDIA各13
例を,20-59才と60才以上の2群に分けて,それ
ぞれのグループの特徴について検討した｡
1.血清IgG,IgAおよびIgM値は,60才以上の
症例において,いずれも非SDIA症例に比べ,
SDIA症例で有意に低い値を示した｡十万,20-
61
59才の症例群においては,IgG値のみSDIA症
例で有意の低下傾向が見られた｡
2.末梢血リンパ球数は,60才以上の症例では,
SDIA症例で,非SDIA症例に比べ有意の低値を
示したが,20-59才の症例では両群間に有意の
差は見られなかった｡
3.気管支肺胞洗浄 (BAL)液中のリンパ球数
は,60才以上のSDIA症例で,非SDIA症例に比
べ有意に少なく,また同時にこれらの症例では
BAL液中好中球が有意に多い傾向が観察され
た｡しかし,20-59才の症例群では,SDIAと
非SDIAの間にいずれも有意の差は見られなかっ
た ｡
これらの結果より,60才以上の症例では,20-
59才の症例群に比べ,副腎皮質ホルモンの長期投
与により,血清IgG,IgAおよびIgM値,末梢血
リンパ球数の減少とともに,BAL液中のリンパ
球減少,好中球増加をきたしやすいことが明らか
にされた｡
キーワード:血清免疫グロブリン値,リンパ球,
好中球,気管支瑞息,副腎皮質ホルモン
